Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs73603059 | chr20:6013041 | T/C | 0 | 177 | 25.67 | 22.63 | 2.93 | KM Plot |
PCPG | rs73709607 | chr8:135493878 | C/T | 0.000123 | 176 | 25.4 | 24.7 | 21.35 | KM Plot |
PCPG | rs73735517 | chr5:1528164 | C/T | 0.000137 | 170 | 25.77 | 20.13 | 13.17 | KM Plot |
PCPG | rs737893 | chr22:21288901 | C/T | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs73862898 | chr3:129053693 | A/G | 0.000333 | 177 | 25.53 | 25.27 | 10.3 | KM Plot |
PCPG | rs7390 | chr12:6571699 | G/A | 0.000272 | 174 | 19.3 | 25.47 | 25.87 | KM Plot |
PCPG | rs73945016 | chr2:105670240 | G/A | 0.000333 | 172 | 26.22 | 25.17 | 20.2 | KM Plot |
PCPG | rs73999972 | chr17:80484429 | G/A | 4.81E-5 | 176 | 25.92 | 20.13 | 7.2 | KM Plot |
PCPG | rs74038417 | chr16:87338824 | G/A | 0.000123 | 173 | 23.03 | 31.2 | 3.17 | KM Plot |
PCPG | rs74038420 | chr16:87340013 | G/A | 0 | 173 | 23.43 | 32.32 | 2.22 | KM Plot |
PCPG | rs740504 | chr14:74426930 | A/G | 9.44E-6 | 177 | 25.17 | 30.63 | 7.4 | KM Plot |
PCPG | rs740505 | chr14:74426854 | T/C | 9.44E-6 | 177 | 25.17 | 30.63 | 7.4 | KM Plot |
PCPG | rs74080519 | chr12:30245141 | A/C | 7.14E-5 | 170 | 25.97 | 23.53 | 16.25 | KM Plot |
PCPG | rs74129714 | chr10:29845007 | C/T | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |
PCPG | rs74129716 | chr10:29845397 | T/C | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |